Bellevue Group AG Q2 2016 Filing
Filed August 12, 2016
Portfolio Value
$531.5B
Holdings
124
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (124 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —Alder Biopharmaceuticals Inc. | 33,000 | $824.0M | 0.16% | |
| 102 | —Endo International PLC | 52,000 | $811.0M | 0.15% | |
| 103 | BIBProShares Trust | 20,500 | $796.0M | 0.15% | |
| 104 | —Quotient Limited | 100,000 | $775.0M | 0.15% | |
| 105 | —Celldex Therapeutics, Inc. | 160,000 | $702.0M | 0.13% | |
| 106 | —Kite Pharma, Inc. | 14,000 | $700.0M | 0.13% | |
| 107 | UTHUnited Therapeutics Corporation | 6,300 | $667.0M | 0.13% | |
| 108 | —Team Health Holdings Inc. | 15,000 | $610.0M | 0.11% | |
| 109 | CYHCommunity Health Systems, Inc. | 50,000 | $603.0M | 0.11% | |
| 110 | NVROEURNevro Corp. | 7,500 | $553.0M | 0.10% | |
| 111 | RMEResMed Inc. | 8,000 | $506.0M | 0.10% | |
| 112 | PODDInsulet Corporation | 15,000 | $454.0M | 0.09% | |
| 113 | MYGNMyriad Genetics, Inc. | 14,000 | $428.0M | 0.08% | |
| 114 | ESPREsperion Therapeutics Inc. | 40,000 | $395.0M | 0.07% | |
| 115 | PENPenumbra, Inc. | 5,000 | $298.0M | 0.06% | |
| 116 | THCTenet Healthcare Corporation | 10,000 | $276.0M | 0.05% | |
| 117 | SGRYSurgery Partners, Inc. | 15,000 | $269.0M | 0.05% | |
| 118 | TBPHTheravance Biopharma, Inc. | 11,428 | $259.0M | 0.05% | |
| 119 | —Heartware International, Inc. | 3,813 | $220.0M | 0.04% | |
| 120 | INFIQInfinity Pharmaceuticals, Inc. | 160,000 | $213.0M | 0.04% | |
| 121 | —Quorum Health Corp | 12,500 | $134.0M | 0.03% | |
| 122 | —Zafgen, Inc. | 20,000 | $120.0M | 0.02% | |
| 123 | TTPHEURTetraphase Pharmaceuticals, Inc. | 22,000 | $95.0M | 0.02% | |
| 124 | CLDNEUREiger BioPharmaceuticals, Inc. | 3,333 | $66.0M | 0.01% |
PreviousPage 2 of 2